Oily Fish Consumption Can Lower CVD Risk in Individuals With Family History

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

WEDNESDAY, Jan. 3, 2024 -- There is a significant interaction between biomarkers of low eicosapentaenoic/docosahexaenoic acids (EPA/DHA) intake and a family history of cardiovascular disease (CVD) in relation to long-term CVD risk, according to a study published online Dec. 4 in Circulation.

Federica Laguzzi, Ph.D., from the Karolinska Institutet in Stockholm, and colleagues assessed interactions between biomarkers of low polyunsaturated fatty acids intake (PUFA levels ≤25th percentile) and family history (having at least one first-degree relative who experienced a CVD event) in relation to long-term CVD risk in a cohort of 40,885 CVD-free adults.

The researchers observed a significant interaction between low EPA/DHA and family history after multivariable adjustment (product term pooled relative risk, 1.09; 95 percent confidence interval, 1.02 to 1.16; P = 0.01). The pooled relative risk (95 percent confidence interval) of CVD was 1.41 (1.30 to 1.54) for combined exposure to low EPA/DHA and family history, while it was 1.25 (1.16 to 1.33) and 1.06 (0.98 to 1.14) for family history alone and EPA/DHA alone, respectively, compared with neither exposure.

"Low blood/tissue levels of n-3 EPA/DHA, reflecting a low intake of fats present in oily fish, may potentiate the risk of CVD in those already at increased risk because of family history," the authors write. "Although these results should be interpreted with caution, it seems reasonable to conclude that our results support the current cardiovascular prevention guidelines regarding the consumption of foods rich in n-3 EPA/DHA (i.e., oily fish), especially for people with a family history of CVD."

One author disclosed ties to Pharmavite.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords